Retinal Toxicity after Initial Administration of Nivolumab and Ipilimumab

Figure 2

(a, b) Early phase of combined fluorescein and indocyanine angiographic examination illustrates choroidal congestion without signs of hyperpermeability or hypofluorescent areas. (c, d) Late phase of combined fluorescein and indocyanine angiographic examination shows discrete extravascular fluorescence (white arrowheads) without signs of retinal vasculitis or loss of choroidal vascular details in both eyes.

(a)

(b)

(c)

(d)